EKF Diagnostics Holdings Plc (EKF) - Net Assets

Latest as of June 2025: GBX72.88 Million GBX ≈ $8.87K USD

Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has net assets worth GBX72.88 Million GBX (≈ $8.87K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX82.43 Million ≈ $10.03K USD) and total liabilities (GBX9.55 Million ≈ $1.16K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EKF Diagnostics Holdings Plc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	GBX72.88 Million
% of Total Assets	88.41%
Annual Growth Rate	28.88%
5-Year Change	-6.38%
10-Year Change	56.59%
Growth Volatility	265.81

EKF Diagnostics Holdings Plc - Net Assets Trend (2001–2024)

This chart illustrates how EKF Diagnostics Holdings Plc's net assets have evolved over time, based on quarterly financial data. Also explore EKF total asset value for the complete picture of this company's asset base.

Annual Net Assets for EKF Diagnostics Holdings Plc (2001–2024)

The table below shows the annual net assets of EKF Diagnostics Holdings Plc from 2001 to 2024. For live valuation and market cap data, see EKF Diagnostics Holdings Plc (EKF) market capitalisation.

Year	Net Assets	Change
2024-12-31	GBX73.21 Million ≈ $8.91K	+7.32%
2023-12-31	GBX68.22 Million ≈ $8.30K	-8.46%
2022-12-31	GBX74.52 Million ≈ $9.07K	-21.34%
2021-12-31	GBX94.74 Million ≈ $11.53K	+21.15%
2020-12-31	GBX78.20 Million ≈ $9.51K	+9.87%
2019-12-31	GBX71.17 Million ≈ $8.66K	+11.37%
2018-12-31	GBX63.90 Million ≈ $7.78K	+5.63%
2017-12-31	GBX60.50 Million ≈ $7.36K	-0.78%
2016-12-31	GBX60.97 Million ≈ $7.42K	+30.41%
2015-12-31	GBX46.75 Million ≈ $5.69K	-46.49%
2014-12-31	GBX87.38 Million ≈ $10.63K	+113.52%
2013-12-31	GBX40.92 Million ≈ $4.98K	+3.79%
2012-12-31	GBX39.43 Million ≈ $4.80K	+5.34%
2011-12-31	GBX37.43 Million ≈ $4.55K	+59.07%
2010-12-31	GBX23.53 Million ≈ $2.86K	+318.67%
2009-12-31	GBX5.62 Million ≈ $683.79	+10.85%
2008-12-31	GBX5.07 Million ≈ $616.87	+1.89%
2007-12-31	GBX4.98 Million ≈ $605.44	+15.75%
2006-12-31	GBX4.30 Million ≈ $523.06	+15.75%
2005-12-31	GBX3.71 Million ≈ $451.89	+19.23%
2004-12-31	GBX3.12 Million ≈ $379.01	+26.73%
2003-12-31	GBX2.46 Million ≈ $299.07	+181.18%
2003-06-30	GBX-3.03 Million ≈ $-368.42	-204.34%
2002-12-31	GBX2.90 Million ≈ $353.09	+1256.07%
2001-12-31	GBX214.00K ≈ $26.04	--

Equity Component Analysis

This analysis shows how different components contribute to EKF Diagnostics Holdings Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 31691.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	GBX55.00 Million	76.04%
Common Stock	GBX4.54 Million	6.27%
Other Comprehensive Income	GBX5.40 Million	7.47%
Other Components	GBX7.39 Million	10.21%
Total Equity	GBX72.33 Million	100.00%

EKF Diagnostics Holdings Plc Competitors by Market Cap

The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their market capitalization.

Company	Market Cap
Focusrite Plc LSE:TUNE	$1.40 Million
BlockMint Technologies Inc V:BKMT	$1.40 Million
Nusantara Inti Corpora Tbk JK:UNIT	$1.40 Million
Wang & Lee Group, Inc. Ordinary Shares NASDAQ:WLGS	$1.40 Million
Arcandor AG DU:ARO	$1.39 Million
Antarctica Limited NSE:ANTGRAPHIC	$1.39 Million
Pharos Energy plc LSE:PHAR	$1.39 Million
elexxion AG XETRA:E8X	$1.39 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EKF Diagnostics Holdings Plc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 67,117,000 to 72,327,000, a change of 5,210,000 (7.8%).
Net income of 6,242,000 contributed positively to equity growth.
Other comprehensive income decreased equity by 1,032,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	GBX6.24 Million	+8.63%
Other Comprehensive Income	GBX-1.03 Million	-1.43%
Total Change	GBX-	7.76%

Book Value vs Market Value Analysis

This analysis compares EKF Diagnostics Holdings Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 166.56x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 18237.62x to 166.56x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2001-12-31	GBX0.00	GBX26.55	x
2002-12-31	GBX0.03	GBX26.55	x
2003-12-31	GBX0.09	GBX26.55	x
2004-12-31	GBX0.09	GBX26.55	x
2005-12-31	GBX0.11	GBX26.55	x
2006-12-31	GBX0.13	GBX26.55	x
2007-12-31	GBX0.15	GBX26.55	x
2008-12-31	GBX0.15	GBX26.55	x
2009-12-31	GBX0.16	GBX26.55	x
2010-12-31	GBX0.24	GBX26.55	x
2011-12-31	GBX0.17	GBX26.55	x
2012-12-31	GBX0.14	GBX26.55	x
2013-12-31	GBX0.14	GBX26.55	x
2014-12-31	GBX0.22	GBX26.55	x
2015-12-31	GBX0.11	GBX26.55	x
2016-12-31	GBX0.13	GBX26.55	x
2017-12-31	GBX0.13	GBX26.55	x
2018-12-31	GBX0.14	GBX26.55	x
2019-12-31	GBX0.15	GBX26.55	x
2020-12-31	GBX0.17	GBX26.55	x
2021-12-31	GBX0.20	GBX26.55	x
2022-12-31	GBX0.16	GBX26.55	x
2023-12-31	GBX0.15	GBX26.55	x
2024-12-31	GBX0.16	GBX26.55	x

Capital Efficiency Dashboard

This dashboard shows how efficiently EKF Diagnostics Holdings Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 8.63%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 12.44%
• Asset Turnover: 0.61x
• Equity Multiplier: 1.13x
Recent ROE (8.63%) is above the historical average (2.78%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2001	137.38%	26.82%	0.20x	25.46x	GBX272.60K
2002	4.93%	8.85%	0.25x	2.22x	GBX-147.20K
2003	-19.32%	-37.25%	0.20x	2.57x	GBX-720.80K
2004	-18.91%	-26.35%	0.34x	2.14x	GBX-900.50K
2005	20.81%	23.70%	0.67x	1.30x	GBX401.60K
2006	13.86%	19.37%	0.60x	1.20x	GBX166.10K
2007	9.34%	136.36%	0.06x	1.12x	GBX-32.60K
2008	-25.78%	-281.08%	0.08x	1.13x	GBX-1.81 Million
2009	-3.61%	-79.30%	0.04x	1.14x	GBX-765.00K
2010	-14.79%	-52.98%	0.18x	1.55x	GBX-5.76 Million
2011	-7.79%	-13.32%	0.37x	1.59x	GBX-6.59 Million
2012	4.70%	7.02%	0.47x	1.43x	GBX-2.06 Million
2013	-2.79%	-3.54%	0.52x	1.50x	GBX-5.17 Million
2014	-6.54%	-14.20%	0.30x	1.56x	GBX-14.39 Million
2015	-79.85%	-123.56%	0.42x	1.55x	GBX-41.77 Million
2016	-0.03%	-0.05%	0.47x	1.36x	GBX-6.06 Million
2017	4.53%	6.53%	0.54x	1.29x	GBX-3.28 Million
2018	15.91%	23.76%	0.52x	1.28x	GBX3.76 Million
2019	5.21%	8.19%	0.52x	1.23x	GBX-3.38 Million
2020	14.31%	17.03%	0.64x	1.30x	GBX3.35 Million
2021	16.84%	19.37%	0.71x	1.22x	GBX6.44 Million
2022	-13.77%	-15.16%	0.75x	1.22x	GBX-17.44 Million
2023	3.50%	4.47%	0.65x	1.20x	GBX-4.36 Million
2024	8.63%	12.44%	0.61x	1.13x	GBX-990.70K

Industry Comparison

This section compares EKF Diagnostics Holdings Plc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $47,885,869
Average return on equity (ROE) among peers: -21.45%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
EKF Diagnostics Holdings Plc (EKF)	GBX72.88 Million	137.38%	0.13x	$1.39 Million
AOTI Inc (AOTI)	$3.41 Million	51.02%	1.74x	$891.93K
Creo Medical Group PLC (CREO)	$1.37 Million	-123.43%	0.18x	$633.60K
Inspiration Healthcare Group PLC (IHC)	$1.65 Million	0.00%	0.38x	$322.92K
NIOX Group PLC (NIOX)	$81.90 Million	19.66%	0.20x	$3.41 Million
Polarean Imaging Plc (POLX)	$8.73 Million	-75.05%	0.25x	$11.75K
Rua Life Sciences PLC (RUA)	$8.51 Million	-17.06%	0.19x	$147.24K
Smith & Nephew PLC (SN)	$273.58 Million	25.01%	1.35x	$118.48 Million
Surgical Innovations Group plc (SUN)	$3.93 Million	-51.73%	0.98x	$51.07K

About EKF Diagnostics Holdings Plc

LSE:EKF UK Medical Devices

Market Cap

$1.39 Million

GBX11.46 Billion GBX

Market Cap Rank

#29998 Global

#743 in UK

Share Price

GBX26.55

Change (1 day)

-0.56%

52-Week Range

GBX19.80 - GBX31.90

All Time High

GBX78.21